Elias Ventre
Research scientist (CRCN) at INRIA Centre d'Université Côte d'Azur, team COMPO.
[first_name].[last_name]@inria.fr
Curriculum
Since October 2024, I'm a research scientist (CRCN) at INRIA, within the team COMPO which is based in Marseille.
From November 2022 to May 2024, I've been a postdoctal fellow at the University of British Columbia, in the team of Geoffrey Schiebinger.
In September 2022, I have obtained a PhD in mathematics applied to cell biology, in the SBDM team at ENS Lyon and the Dracula team at INRIA and UCBL Lyon 1, supervized by Thibault Espinasse, Olivier Gandrillon and Thomas Lepoutre.
Before that, I have also obtained a master's degree in Architecture and Building engineering in 2015, and have worked during 2 years in the group Builders & Partners.
Here is my CV for more details.
Research interest
My work falls within the broader category of mechanistic generative modeling: calibrating mechanistic models of cellular dynamics, in particular parameterized by Gene Regulatory Networks (GRNs), from single-cell data. More specifically:
- Multiscale analysis of stochastic hybid processes,
- Inferring Gene Regulatory Networks from single-cell datasets,
- Cell trajectory reconstruction from single-cell datasets using entropy minimization problems.
Recently, these approaches have found a particularly important application in the analysis of data from patient-derived organoids, in particular for rare pediatric cancers, for which databases are only just emerging and make the use of large, data-hungry AI models poorly suited. In this context, I collaborate with members of the Southrock consortium, at the CRCM and the CRCL.
Current projects
- PEDIAMOD – Innovative models in pediatric oncology (2024–2027, 120k€). Leader: Laura Broutier. Postdoc: Giada Fiandaca.
- Oxstar – OXphos-targeted Stratification and Therapeutic Approaches in Rhabdomyosarcoma: pre-clinical evaluation of a new class of therapeutic compounds (2026–2030, 110k€). Leader: Martine Cordier-Bussat.
- Pedia-ORI2026 – A pan-pediatric cancer integrative approach to identify dysregulated developmental modules driving tumor initiation (2026–2030, 120k€). Leader: Thomas Mercher.
- SCITCH – From Stem Cell Interactions to Tissue Homeostasis: multiscale modelling and statistical inference (2026–2029, 19k€). Leader: Nicolas Dray.